Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

KB-0742

Product Specifications

UNSPSC Description

KB-0742 is a potent, selective and orally active CDK9 inhibitor with an IC50 of 6 nM for CDK9/cyclin T1. KB-0742 is selective for CDK9/cyclin T1 with >50-fold selectivity over other CDK kinases. KB-0742 has potent anti-tumor activity[1].

Target Antigen

CDK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/kb-0742.html

Smiles

N[C@@H]1C[C@@H](NC2=CC(C(CC)CC)=NC3=CC=NN23)CC1

Molecular Weight

287.40

References & Citations

[1]André Richters, et al. Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors. Cell Chem Biol. 2020 Oct 20;S2451-9456(20)30380-9.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-137478/KB-0742-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-137478/KB-0742-SDS-MedChemExpress.pdf

CAS Number

2416873-83-9

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mouse Anti-Human CD34 Class I Monoclonal Antibody, Unconjugated Clone B-C34
MBS335116-01 200 Tests

Mouse Anti-Human CD34 Class I Monoclonal Antibody, Unconjugated Clone B-C34

Ask
View Details
Mouse Anti-Human CD34 Class I Monoclonal Antibody, Unconjugated Clone B-C34
MBS335116-02 5x 200 Tests

Mouse Anti-Human CD34 Class I Monoclonal Antibody, Unconjugated Clone B-C34

Ask
View Details
OSGEPL1 Antibody
CSB-PA884466ESR2HU-01 50 µL

OSGEPL1 Antibody

Ask
View Details
OSGEPL1 Antibody
CSB-PA884466ESR2HU-02 100 µL

OSGEPL1 Antibody

Ask
View Details
OR1N2 Peptide - C-terminal region
MBS3243584-01 0.1 mg

OR1N2 Peptide - C-terminal region

Ask
View Details
OR1N2 Peptide - C-terminal region
MBS3243584-02 5x 0.1 mg

OR1N2 Peptide - C-terminal region

Ask
View Details